Klaus V. Toyka - Publications

Department of Neurology University of Würzburg, Würzburg, Bayern, Germany 

198 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Grünewald B, Lange MD, Werner C, O'Leary A, Weishaupt A, Popp S, Pearce DA, Wiendl H, Reif A, Pape HC, Toyka KV, Sommer C, Geis C. Defective synaptic transmission causes disease signs in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis. Elife. 6. PMID 29135436 DOI: 10.7554/eLife.28685  0.36
2016 Ip CW, Isaias IU, Kusche-Tekin BB, Klein D, Groh J, O'Leary A, Knorr S, Higuchi T, Koprich JB, Brotchie JM, Toyka KV, Reif A, Volkmann J. Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury. Acta Neuropathologica Communications. 4: 108. PMID 27716431 DOI: 10.1186/s40478-016-0375-7  0.32
2016 Schneider-Gold C, Krenzer M, Klinker E, Mansouri-Thalegani B, Müllges W, Toyka KV, Gold R. Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration. Therapeutic Advances in Neurological Disorders. 9: 297-303. PMID 27366236 DOI: 10.1177/1756285616637046  0.6
2016 Baum P, Kosacka J, Estrela-Lopis I, Woidt K, Serke H, Paeschke S, Stockinger M, Klöting N, Blüher M, Dorn M, Classen J, Thiery J, Bechmann I, Toyka KV, Nowicki M. The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN). Metabolism: Clinical and Experimental. 65: 391-405. PMID 26975531 DOI: 10.1016/j.metabol.2015.11.002  0.6
2015 Werner C, Pauli M, Doose S, Weishaupt A, Haselmann H, Grünewald B, Sauer M, Heckmann M, Toyka KV, Asan E, Sommer C, Geis C. Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition. Brain : a Journal of Neurology. PMID 26582558 DOI: 10.1093/brain/awv324  0.6
2015 Steinbeck JA, Jaiswal MK, Calder EL, Kishinevsky S, Weishaupt A, Toyka KV, Goldstein PA, Studer L. Functional Connectivity under Optogenetic Control Allows Modeling of Human Neuromuscular Disease. Cell Stem Cell. PMID 26549107 DOI: 10.1016/j.stem.2015.10.002  0.6
2015 Üçeyler N, Necula G, Wagemann E, Toyka KV, Sommer C. Endoneurial edema in sural nerve may indicate recent onset inflammatory neuropathy. Muscle & Nerve. PMID 26439587 DOI: 10.1002/mus.24930  0.6
2015 Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL, Haller A, Lear-Kaul K, Kandasmy B, Amato M, Wood E, Durairaj V, Fogt F, Tamhankar MA, Grossniklaus HE, ... ... Toyka KV, et al. Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. Jama Neurology. 1-7. PMID 26349037 DOI: 10.1001/jamaneurol.2015.2101  0.6
2015 Üçeyler N, Geng A, Reiners K, Toyka KV, Sommer C. Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients. Journal of Neurology. 262: 2092-100. PMID 26092519 DOI: 10.1007/s00415-015-7813-5  0.6
2015 Simon CM, Rauskolb S, Gunnersen JM, Holtmann B, Drepper C, Dombert B, Braga M, Wiese S, Jablonka S, Pühringer D, Zielasek J, Hoeflich A, Silani V, Wolf E, Kneitz S, ... ... Toyka KV, et al. Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy. Acta Neuropathologica. PMID 26025657 DOI: 10.1007/s00401-015-1446-8  0.6
2015 Geis C, Ritter C, Ruschil C, Weishaupt A, Grünewald B, Stoll G, Holmoy T, Misu T, Fujihara K, Hemmer B, Stadelmann C, Bennett JL, Sommer C, Toyka KV. The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model. Experimental Neurology. 265: 8-21. PMID 25542977 DOI: 10.1016/j.expneurol.2014.12.015  0.6
2015 Werner C, Haselmann H, Weishaupt A, Toyka KV, Sommer C, Geis C. Stiff person-syndrome IgG affects presynaptic GABAergic release mechanisms. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 357-62. PMID 24990310 DOI: 10.1007/s00702-014-1268-1  0.6
2014 Krieger F, Elflein N, Saenger S, Wirthgen E, Rak K, Frantz S, Hoeflich A, Toyka KV, Metzger F, Jablonka S. Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1. Brain : a Journal of Neurology. 137: 1374-93. PMID 24681663 DOI: 10.1093/brain/awu059  0.6
2014 Niemann A, Huber N, Wagner KM, Somandin C, Horn M, Lebrun-Julien F, Angst B, Pereira JA, Halfter H, Welzl H, Feltri ML, Wrabetz L, Young P, Wessig C, Toyka KV, et al. The Gdap1 knockout mouse mechanistically links redox control to Charcot-Marie-Tooth disease. Brain : a Journal of Neurology. 137: 668-82. PMID 24480485 DOI: 10.1093/brain/awt371  0.6
2014 Nowicki M, Baum P, Kosacka J, Stockinger M, Klöting N, Blüher M, Bechmann I, Toyka KV. Effects of isoflurane anesthesia on F-waves in the sciatic nerve of the adult rat. Muscle & Nerve. 50: 257-61. PMID 24347162 DOI: 10.1002/mus.24150  0.6
2013 Kosacka J, Nowicki M, Blüher M, Baum P, Stockinger M, Toyka KV, Klöting I, Stumvoll M, Serke H, Bechmann I, Klöting N. Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy. Experimental Neurology. 250: 125-35. PMID 24095727 DOI: 10.1016/j.expneurol.2013.09.017  0.6
2013 Camara M, Beyersdorf N, Fischer HJ, Herold MJ, Ip CW, van den Brandt J, Toyka KV, Taurog JD, Hünig T, Herrmann T, Reichardt HM, Weishaupt A, Kerkau T. CD8⁺ T cell help is required for efficient induction of EAE in Lewis rats. Journal of Neuroimmunology. 260: 17-27. PMID 23664330 DOI: 10.1016/j.jneuroim.2013.04.014  0.6
2013 Morsch M, Reddel SW, Ghazanfari N, Toyka KV, Phillips WD. Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. The Journal of Physiology. 591: 2747-62. PMID 23440963 DOI: 10.1113/jphysiol.2013.251827  0.6
2013 Hansen N, Grünewald B, Weishaupt A, Colaço MN, Toyka KV, Sommer C, Geis C. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Experimental Neurology. 239: 202-9. PMID 23099416 DOI: 10.1016/j.expneurol.2012.10.013  0.6
2012 Gajdos P, Chevret S, Toyka KV. Intravenous immunoglobulin for myasthenia gravis. The Cochrane Database of Systematic Reviews. 12: CD002277. PMID 23235588 DOI: 10.1002/14651858.CD002277.pub4  0.6
2012 Horn M, Baumann R, Pereira JA, Sidiropoulos PN, Somandin C, Welzl H, Stendel C, Lühmann T, Wessig C, Toyka KV, Relvas JB, Senderek J, Suter U. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. Brain : a Journal of Neurology. 135: 3567-83. PMID 23171661 DOI: 10.1093/brain/aws275  0.6
2012 Zeller D, Dang SY, Weise D, Rieckmann P, Toyka KV, Classen J. Excitability decreasing central motor plasticity is retained in multiple sclerosis patients. Bmc Neurology. 12: 92. PMID 22974055 DOI: 10.1186/1471-2377-12-92  0.6
2012 Brecht I, Weissbrich B, Braun J, Toyka KV, Weishaupt A, Buttmann M. Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis. Plos One. 7: e40431. PMID 22792316 DOI: 10.1371/journal.pone.0040431  0.6
2012 Morsch M, Reddel SW, Ghazanfari N, Toyka KV, Phillips WD. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors. Experimental Neurology. 237: 286-95. PMID 22789393 DOI: 10.1016/j.expneurol.2012.06.034  0.6
2012 Pan B, Grünewald B, Nguyen T, Farah M, Polydefkis M, McDonald J, Schramm LP, Toyka KV, Höke A, Griffin JW. The lateral thoracic nerve and the cutaneous maximus muscle--a novel in vivo model system for nerve degeneration and regeneration studies. Experimental Neurology. 236: 6-18. PMID 22361024 DOI: 10.1016/j.expneurol.2012.02.006  0.6
2012 Geis C, Grünewald B, Weishaupt A, Wultsch T, Toyka KV, Reif A, Sommer C. Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 981-5. PMID 22331304 DOI: 10.1007/s00702-012-0773-3  0.6
2012 Schwab N, Ulzheimer JC, Fox RJ, Schneider-Hohendorf T, Kieseier BC, Monoranu CM, Staugaitis SM, Welch W, Jilek S, Du Pasquier RA, Brück W, Toyka KV, Ransohoff RM, Wiendl H. Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control. Neurology. 78: 458-67; discussion 4. PMID 22302546 DOI: 10.1212/WNL.0b013e3182478d4b  0.6
2011 Latov N, Dalakas M, Vallat JM, Donofrio P, Hartung HP, Toyka KV. Biomarkers in the diagnosis and therapy of CIDP: Proceedings of the Biomarkers Faculty Meeting; June 8-9, 2010, Athens, Greece. Journal of the Peripheral Nervous System : Jpns. 16: 1-2. PMID 21696489 DOI: 10.1111/j.1529-8027.2011.00297.x  0.6
2011 Devigili G, Uçeyler N, Beck M, Reiners K, Stoll G, Toyka KV, Sommer C. Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment. Acta Neuropathologica. 122: 343-52. PMID 21626035 DOI: 10.1007/s00401-011-0837-8  0.6
2011 Hohlfeld R, Toyka KV. Multiple sclerosis: Updates on pathogenesis and therapy. Report from the 9th MS Symposium of the German Multiple Sclerosis Society | Multiple Sklerose: Updates zu pathogenese und therapie: Bericht vom 9. MS-symposium der deutschen multiplen sklerose gesellschaft Nervenarzt. 82: 1026-1035. PMID 21424411 DOI: 10.1007/s00115-011-3264-0  0.6
2011 Geis C, Weishaupt A, Grünewald B, Wultsch T, Reif A, Gerlach M, Dirkx R, Solimena M, Perani D, Heckmann M, Toyka KV, Folli F, Sommer C. Human stiff-person syndrome IgG induces anxious behavior in rats. Plos One. 6: e16775. PMID 21346811 DOI: 10.1371/journal.pone.0016775  0.6
2011 Zeller D, Dang SY, Stefan K, Biller A, Bartsch A, Saur D, Bendszus M, Rieckmann P, Toyka KV, Classen J. Functional role of ipsilateral motor areas in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 578-83. PMID 20980484 DOI: 10.1136/jnnp.2010.219964  0.6
2011 Hummel HD, Rath JC, Wiendl H, Hetzel W, Bargou RC, Toyka KV, Sommer C, Einsele H, Topp MS. Auto-SCT in severe paraproteinemic neuropathy Bone Marrow Transplantation. 46: 457-459. PMID 20577220 DOI: 10.1038/bmt.2010.124  0.6
2010 Geis C, Weishaupt A, Hallermann S, Grünewald B, Wessig C, Wultsch T, Reif A, Byts N, Beck M, Jablonka S, Boettger MK, Üçeyler N, Fouquet W, Gerlach M, Meinck HM, ... ... Toyka KV, et al. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain : a Journal of Neurology. 133: 3166-80. PMID 20884644 DOI: 10.1093/brain/awq253  0.6
2010 Üçeyler N, Kafke W, Riediger N, He L, Necula G, Toyka KV, Sommer C. Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy Neurology. 74: 1806-1813. PMID 20513817 DOI: 10.1212/WNL.0b013e3181e0f7b3  0.6
2010 Schwab N, Zozulya AL, Kieseier BC, Toyka KV, Wiendl H. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 184: 5368-74. PMID 20357264 DOI: 10.4049/jimmunol.0903662  0.6
2010 Uçeyler N, Devigili G, Toyka KV, Sommer C. Skin biopsy as an additional diagnostic tool in non-systemic vasculitic neuropathy. Acta Neuropathologica. 120: 109-16. PMID 20204385 DOI: 10.1007/s00401-010-0662-5  0.6
2010 Zeller D, Aufm Kampe K, Biller A, Stefan K, Gentner R, Schütz A, Bartsch A, Bendszus M, Toyka KV, Rieckmann P, Classen J. Rapid-onset central motor plasticity in multiple sclerosis Neurology. 74: 728-735. PMID 20194911 DOI: 10.1212/WNL.0b013e3181d31dcf  0.6
2010 Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, Steele AD, Toyka KV, Nave KA, Weis J, Aguzzi A. Axonal prion protein is required for peripheral myelin maintenance. Nature Neuroscience. 13: 310-8. PMID 20098419 DOI: 10.1038/nn.2483  0.6
2010 Boettger MK, Weishaupt A, Geis C, Toyka KV, Sommer C. Mild experimental autoimmune encephalitis as a tool to induce blood-brain barrier dysfunction. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 165-9. PMID 19946712 DOI: 10.1007/s00702-009-0342-6  0.6
2009 Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Annals of Neurology. 66: 171-83. PMID 19705413 DOI: 10.1002/ana.21705  0.6
2009 Chuang WY, Ströbel P, Belharazem D, Rieckmann P, Toyka KV, Nix W, Schalke B, Gold R, Kiefer R, Klinker E, Opitz A, Inoue M, Kuo TT, Müller-Hermelink HK, Marx A. The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis. Genes and Immunity. 10: 667-72. PMID 19693092 DOI: 10.1038/gene.2009.64  0.6
2009 Bayas A, Stasiolek M, Kruse N, Toyka KV, Selmaj K, Gold R. Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis Clinical and Experimental Immunology. 157: 332-342. PMID 19664140 DOI: 10.1111/j.1365-2249.2009.03964.x  0.6
2009 Geis C, Beck M, Jablonka S, Weishaupt A, Toyka KV, Sendtner M, Sommer C. Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca(2+)]i rise in embryonic motoneurons. Neurobiology of Disease. 36: 191-9. PMID 19631746 DOI: 10.1016/j.nbd.2009.07.011  0.6
2009 Buttmann M, Toyka KV. Can we get rid of neutralizing antibodies against interferon-β?: EDITORIAL European Journal of Neurology. 16: 7-9. PMID 19087143 DOI: 10.1111/j.1468-1331.2008.02333.x  0.6
2009 Gold R, Hartung HP, Hohlfeld R, Wiendl H, Kieseier BC, Linker RA, Schmidt S, Toyka KV, Adams O, Baum K, Bayas A, Bitsch A, Buck D, Chan A, Derfuß T, et al. Therapy of multiple sclerosis with monoclonal antibodies: Results and recommendations of a symposium of the medical advisory board of the german MS society | Therapie der multiplen sklerose mit monoklonalen antikörpern: Ergebnisse und empfehlungen einer arbeitstagung des ärztlichen beirats der deutschen multiple sklerose gesellschaft Aktuelle Neurologie. 36: 334-344. DOI: 10.1055/s-0029-1220429  0.6
2008 Gold R, Hohlfeld R, Toyka KV. Progress in the treatment of myasthenia gravis. Therapeutic Advances in Neurological Disorders. 1: 36-51. PMID 21180568 DOI: 10.1177/1756285608093888  0.6
2008 Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, et al. Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations Journal of Neurology. 255: 1449-1463. PMID 19005625 DOI: 10.1007/s00415-008-0061-1  0.6
2008 Stenner MP, Waschbisch A, Buck D, Doerck S, Einsele H, Toyka KV, Wiendl H. Effects of natalizumab treatment on Foxp3+ T regulatory cells. Plos One. 3: e3319. PMID 18836525 DOI: 10.1371/journal.pone.0003319  0.6
2008 Schäfers M, Neukirchen S, Toyka KV, Sommer C. Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy. Journal of the Peripheral Nervous System : Jpns. 13: 81-91. PMID 18346234 DOI: 10.1111/j.1529-8027.2008.00161.x  0.6
2008 Vlcková-Moravcová E, Bednarík J, Dusek L, Toyka KV, Sommer C. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle & Nerve. 37: 50-60. PMID 17763459 DOI: 10.1002/mus.20889  0.6
2008 Gold R, Schneider-Gold C, Toyka KV. Progress in pathogenesis and treatment of myasthenia gravis and lambert eaton myasthenic syndrome | Fortschritte in pathogenese und therapie der myasthenia gravis und des lambert-eaton-myasthenen syndroms Aktuelle Neurologie. 35: 192-203. DOI: 10.1055/s-2007-986407  0.6
2008 Gold R, Toyka KV. Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, and axonal degeneration and regeneration Neuroimmune Pharmacology. 257-262. DOI: 10.1007/978-0-387-72573-4_19  0.6
2007 Hofstetter HH, Grau C, Buttmann M, Forsthuber TG, Gaupp S, Toyka KV, Gold R. The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells. Cytokine. 40: 35-43. PMID 17881243 DOI: 10.1016/j.cyto.2007.07.192  0.6
2007 Tersar K, Boentert M, Berger P, Bonneick S, Wessig C, Toyka KV, Young P, Suter U. Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2. Human Molecular Genetics. 16: 2991-3001. PMID 17855448 DOI: 10.1093/hmg/ddm257  0.6
2007 Buchwald B, Zhang G, Vogt-Eisele AK, Zhang W, Ahangari R, Griffin JW, Hatt H, Toyka KV, Sheikh KA. Anti-ganglioside antibodies alter presynaptic release and calcium influx. Neurobiology of Disease. 28: 113-21. PMID 17720506 DOI: 10.1016/j.nbd.2007.07.008  0.6
2007 Chan A, Lee DH, Linker R, Mohr A, Toyka KV, Gold R. Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease. Journal of Neurology. 254: 1604-6. PMID 17713826 DOI: 10.1007/s00415-007-0593-9  0.6
2007 Uçeyler N, Rogausch JP, Toyka KV, Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology. 69: 42-9. PMID 17606879 DOI: 10.1212/01.wnl.0000265062.92340.a5  0.6
2007 Kosinski CM, Schlangen C, Gellerich FN, Gizatullina Z, Deschauer M, Schiefer J, Young AB, Landwehrmeyer GB, Toyka KV, Sellhaus B, Lindenberg KS. Myopathy as a first symptom of Huntington's disease in a Marathon runner. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1637-40. PMID 17534945 DOI: 10.1002/mds.21550  0.6
2007 Hofstetter HH, Toyka KV, Tary-Lehmann M, Lehmann PV. Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. Journal of Immunology (Baltimore, Md. : 1950). 178: 1372-8. PMID 17237384  0.6
2007 Siglienti I, Chan A, Kleinschnitz C, Jander S, Toyka KV, Gold R, Stoll G. Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions. Journal of Neuropathology and Experimental Neurology. 66: 47-56. PMID 17204936 DOI: 10.1097/nen.0b013e31802d47b4  0.6
2007 Toyka KV, Gold R. Treatment of myasthenia gravis Schweizer Archiv Fur Neurologie Und Psychiatrie. 158: 309-321.  0.6
2007 Schneider-Gold C, Toyka KV. Myasthenia gravis: Pathogenesis and immunotherapy | Myasthenia gravis: Pathogenese und immuntherapie Deutsches Arzteblatt. 104: 420-426.  0.6
2006 Toyka KV. Ptosis in myasthenia gravis: extended fatigue and recovery bedside test. Neurology. 67: 1524. PMID 17060601 DOI: 10.1212/01.wnl.0000240069.24338.c8  0.6
2006 Henze T, Rieckmann P, Toyka KV. Symptomatic treatment of multiple sclerosis: Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society European Neurology. 56: 78-105. PMID 16966832 DOI: 10.1159/000095699  0.6
2006 Tischner D, Weishaupt A, van den Brandt J, Müller N, Beyersdorf N, Ip CW, Toyka KV, Hünig T, Gold R, Kerkau T, Reichardt HM. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. Brain : a Journal of Neurology. 129: 2635-47. PMID 16921176 DOI: 10.1093/brain/awl213  0.6
2006 Hofstetter HH, Lühder F, Toyka KV, Gold R. IL-17 production by thymocytes upon CD3 stimulation and costimulation with microbial factors. Cytokine. 34: 184-97. PMID 16815032 DOI: 10.1016/j.cyto.2006.04.014  0.6
2006 Stasiolek M, Bayas A, Kruse N, Wieczarkowiecz A, Toyka KV, Gold R, Selmaj K. Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain : a Journal of Neurology. 129: 1293-305. PMID 16513684 DOI: 10.1093/brain/awl043  0.6
2006 Kallmann BA, Fackelmann S, Toyka KV, Rieckmann P, Reiners K. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis Multiple Sclerosis. 12: 58-65. PMID 16459720 DOI: 10.1191/135248506ms1244oa  0.6
2006 Hofstetter HH, Toyka KV, Gold R. Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis. Neuroscience Letters. 391: 127-30. PMID 16198481 DOI: 10.1016/j.neulet.2005.08.042  0.6
2005 Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, Toyka KV, Gold R. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cellular Immunology. 237: 123-30. PMID 16386239 DOI: 10.1016/j.cellimm.2005.11.002  0.6
2005 Bonneick S, Boentert M, Berger P, Atanasoski S, Mantei N, Wessig C, Toyka KV, Young P, Suter U. An animal model for Charcot-Marie-Tooth disease type 4B1. Human Molecular Genetics. 14: 3685-95. PMID 16249189 DOI: 10.1093/hmg/ddi400  0.6
2005 Hofstetter HH, Mössner R, Lesch KP, Linker RA, Toyka KV, Gold R. Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE Clinical and Experimental Immunology. 142: 39-44. PMID 16178854 DOI: 10.1111/j.1365-2249.2005.02901.x  0.6
2005 Gold R, Bayas A, Toyka KV. Autoimmune neuropathien - Current aspects of immunopathologic diagnostics and therapy | Immunneuropathien - Aktuelle aspekte der diagnostik und therapie Nervenarzt. 76: 1009-1023. PMID 16080020 DOI: 10.1007/s00115-005-1942-5  0.6
2005 Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka KV, Lin CH, Hanke T, Hünig T, Kerkau T, Gold R. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 202: 445-55. PMID 16061730 DOI: 10.1084/jem.20051060  0.6
2005 Bates D, Toyka KV, Wolinsky JS, Arnold D. Disease management in multiple sclerosis. European Neurology. 53: 203-5. PMID 15976505 DOI: 10.1159/000086480  0.6
2005 Kroner A, Vogel F, Kolb-Mäurer A, Kruse N, Toyka KV, Hemmer B, Rieckmann P, Mäurer M. Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis Journal of Neuroimmunology. 165: 161-165. PMID 15932772 DOI: 10.1016/j.jneuroim.2005.03.012  0.6
2005 Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Mäurer M, Wiendl H. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Annals of Neurology. 58: 50-7. PMID 15912506 DOI: 10.1002/ana.20514  0.6
2005 Reinhardt M, Hauff P, Linker RA, Briel A, Gold R, Rieckmann P, Becker G, Toyka KV, Mäurer M, Schirner M. Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ). Neuroimage. 27: 267-78. PMID 15905104 DOI: 10.1016/j.neuroimage.2005.04.019  0.6
2005 Rieckmann P, Kruse N, Nagelkerken L, Beckmann K, Miller D, Polman C, Dahlke F, Toyka KV, Hartung HP, Stürzebecher S. Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of Interferon beta-1b in patients with Secondary Progressive Multiple Sclerosis Journal of Neurology. 252: 526-533. PMID 15895275 DOI: 10.1007/s00415-005-0681-7  0.6
2005 Jung S, Zimmer S, Lüneberg E, Frosch M, Karch H, Korn T, Toyka KV. Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis--a potential mechanism in Guillain-Barre syndrome? Neuroscience Letters. 381: 175-8. PMID 15882812 DOI: 10.1016/j.neulet.2005.02.028  0.6
2005 Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR. Corticosteroids for myasthenia gravis Cochrane Database of Systematic Reviews (Online). CD002828. PMID 15846640  0.6
2005 Linker RA, Rott E, Hofstetter HH, Hanke T, Toyka KV, Gold R. EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses. Neurobiology of Disease. 19: 218-28. PMID 15837577 DOI: 10.1016/j.nbd.2004.12.017  0.6
2005 Sommer C, Weishaupt A, Brinkhoff J, Biko L, Wessig C, Gold R, Toyka KV. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet (London, England). 365: 1406-11. PMID 15836889 DOI: 10.1016/S0140-6736(05)66376-3  0.6
2005 Buchwald B, Ahangari R, Weishaupt A, Toyka KV. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins. Muscle & Nerve. 31: 487-94. PMID 15685615 DOI: 10.1002/mus.20269  0.6
2005 Berghoff M, Samsam M, Müller M, Kobsar I, Toyka KV, Kiefer R, Mäurer M, Martini R. Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene. Molecular and Cellular Neurosciences. 28: 118-27. PMID 15607947 DOI: 10.1016/j.mcn.2004.09.001  0.6
2005 Chan A, Weilbach FX, Toyka KV, Gold R. Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients Clinical and Experimental Immunology. 139: 152-158. PMID 15606626 DOI: 10.1111/j.1365-2249.2005.02653.x  0.6
2005 Mäurer M, Toyka KV, Martini R. The role of the immune system in hereditary neuropathies | Die rolle des immunsystems bei hereditären demyelinisierenden neuropathien Nervenarzt. 76: 690-700. PMID 15580468 DOI: 10.1007/s00115-004-1841-1  0.6
2005 Sommer C, Koch S, Lammens M, Gabreels-Festen A, Stoll G, Toyka KV. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP Neurology. 65: 1924-1929. DOI: 10.1212/01.wnl.0000188879.19900.b7  0.6
2005 Wessig C, Reiners K, Koltzenburg M, Solymosi L, Toyka KV, Stoll C, Bendszus M. MRI changes of nerve and muscle after nerve lesions: Correlation with electromyography and histology | MR-veränderungen von nerv und muskel bei läsionen des peripheren nervs: Korrelation mit elektromyographie und histologie Klinische Neurophysiologie. 36: 20-28. DOI: 10.1055/s-2004-834670  0.6
2005 Gold R, Stoll G, Kieseier BC, Hartung HP, Toyka KV. Experimental Autoimmune Neuritis Peripheral Neuropathy. 1: 609-633. DOI: 10.1016/B978-0-7216-9491-7.50030-2  0.6
2005 Hartung HP, Kieseier BC, Gold R, Stoll G, Toyka KV. Introduction to Immune Reactions in the Peripheral Nervous System Peripheral Neuropathy. 1: 559-572. DOI: 10.1016/B978-0-7216-9491-7.50028-4  0.6
2004 Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, et al. Escalating immunotherapy of multiple sclerosis--new aspects and practical application. Journal of Neurology. 251: 1329-39. PMID 15592728 DOI: 10.1007/s00415-004-0537-6  0.6
2004 Henze T, Toyka KV. Treatment of multiple sclerosis symptoms: The necessity of guidelines | Therapie von MS-symptomen: Auch hier sind leitlinien notwendig Nervenarzt. 75: S1. PMID 15480525  0.6
2004 Bendszus M, Koltzenburg M, Bartsch AJ, Goldbrunner R, Günthner-Lengsfeld T, Weilbach FX, Roosen K, Toyka KV, Solymosi L. Heparin and air filters reduce embolic events caused by intra-arterial cerebral angiography: a prospective, randomized trial. Circulation. 110: 2210-5. PMID 15466635 DOI: 10.1161/01.CIR.0000144301.82391.85  0.6
2004 Schneider-Gold C, Beer M, Köstler H, Buchner S, Sandstede J, Hahn D, Toyka KV. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Muscle & Nerve. 30: 636-44. PMID 15452841 DOI: 10.1002/mus.20156  0.6
2004 Martini R, Toyka KV. Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. The Lancet. Neurology. 3: 457-65. PMID 15261606 DOI: 10.1016/S1474-4422(04)00822-1  0.6
2004 Kroner A, Mäurer M, Loserth S, Kleinschnitz C, Hemmer B, Rosche B, Toyka KV, Rieckmann P. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis Tissue Antigens. 64: 70-73. PMID 15191525 DOI: 10.1111/j.1399-0039.2004.00240.x  0.6
2004 Mäurer M, Stoll G, Toyka KV. Multifocal motor neuropathy presenting as chronic progressive proximal leg weakness. Neuromuscular Disorders : Nmd. 14: 380-2. PMID 15145341 DOI: 10.1016/j.nmd.2004.02.013  0.6
2004 Flachenecker P, Bihler I, Weber F, Gottschalk M, Toyka KV, Rieckmann P. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Multiple Sclerosis (Houndmills, Basingstoke, England). 10: 165-9. PMID 15124762 DOI: 10.1191/1352458504ms991oa  0.6
2004 Stoll G, Wesemeier C, Gold R, Solymosi L, Toyka KV, Bendszus M. In vivo monitoring of macrophage infiltration in experimental autoimmune neuritis by magnetic resonance imaging. Journal of Neuroimmunology. 149: 142-6. PMID 15020074 DOI: 10.1016/j.jneuroim.2003.12.024  0.6
2004 Kahl KG, Schmidt HH, Jung S, Sherman P, Toyka KV, Zielasek J. Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response. Neuroscience Letters. 358: 58-62. PMID 15016434 DOI: 10.1016/j.neulet.2003.12.095  0.6
2004 Schoser BG, Schneider-Gold C, Kress W, Goebel HH, Reilich P, Koch MC, Pongratz DE, Toyka KV, Lochmüller H, Ricker K. Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle & Nerve. 29: 275-81. PMID 14755494 DOI: 10.1002/mus.10545  0.6
2004 Jung S, Gaupp S, Korn T, Köllner G, Hartung HP, Toyka KV. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization. Journal of Neuroscience Research. 75: 524-35. PMID 14743436 DOI: 10.1002/jnr.10879  0.6
2004 Visan L, Visan IA, Weishaupt A, Hofstetter HH, Toyka KV, Hünig T, Gold R. Tolerance induction by intrathymic expression of P0. Journal of Immunology (Baltimore, Md. : 1950). 172: 1364-70. PMID 14734711  0.6
2004 Weilbach FX, Chan A, Toyka KV, Gold R. The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis Clinical and Experimental Immunology. 135: 49-55. PMID 14678264 DOI: 10.1111/j.1365-2249.2004.02344.x  0.6
2004 Johannssen K, Rupprecht K, Toyka KV, Mäurer M. Primary progressive multiple sclerosis: Usage of new recommended guidelines prevents misdiagnosis | Primär chronisch progrediente multiple sklerose (MS): Das einhalten der neuen diagnostischen kriterien verhindert fehldiagnosen Aktuelle Neurologie. 31: 407-410. DOI: 10.1055/s-2004-828364  0.6
2003 Jann S, Bramerio MA, Beretta S, Koch S, Defanti CA, Toyka KV, Sommer C. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP Neurology. 61: 1607-1610. PMID 14663052  0.6
2003 Kleinschnitz C, Bendszus M, Frank M, Solymosi L, Toyka KV, Stoll G. In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 23: 1356-61. PMID 14600443 DOI: 10.1097/01.WCB.0000090505.76664.DB  0.6
2003 Flachenecker P, Rufer A, Bihler I, Hippel C, Reiners K, Toyka KV, Kesselring J. Fatigue in MS is related to sympathetic vasomotor dysfunction Neurology. 61: 851-853. PMID 14504339  0.6
2003 Wolinsky JS, Toyka KV, Kappos L, Grossberg SE. Interferon-beta antibodies: implications for the treatment of MS. The Lancet. Neurology. 2: 528. PMID 12941572 DOI: 10.1016/S1474-4422(03)00499-X  0.6
2003 Chan A, Seguin R, Magnus T, Papadimitriou C, Toyka KV, Antel JP, Gold R. Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta. Glia. 43: 231-42. PMID 12898702 DOI: 10.1002/glia.10258  0.6
2003 Wessig C, Klein R, Schneider MF, Toyka KV, Naumann M, Sommer C. Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome. Neurology. 61: 195-8. PMID 12874398  0.6
2003 Flachenecker P, Schneider C, Cursiefen S, Ricker K, Toyka KV, Reiners K. Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM). Neuromuscular Disorders : Nmd. 13: 289-93. PMID 12868497 DOI: 10.1016/S0960-8966(02)00277-8  0.6
2003 Schmidt J, Elflein K, Stienekemeier M, Rodriguez-Palmero M, Schneider C, Toyka KV, Gold R, Hünig T. Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies. Journal of Neuroimmunology. 140: 143-52. PMID 12864982 DOI: 10.1016/S0165-5728(03)00182-6  0.6
2003 Gold R, Dalakas MC, Toyka KV. Immunotherapy in autoimmune neuromuscular disorders. The Lancet. Neurology. 2: 22-32. PMID 12849298 DOI: 10.1016/S1474-4422(03)00264-3  0.6
2003 Toyka KV, Schneider-Gold C. Oculomotor signs in Lambert-Eaton myasthenic syndrome-coincidence with myasthenia gravis. Annals of Neurology. 54: 135-6; author reply . PMID 12838533 DOI: 10.1002/ana.10640  0.6
2003 Kahl KG, Zielasek J, Uttenthal LO, Rodrigo J, Toyka KV, Schmidt HH. Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. Journal of Neuroscience Research. 73: 198-205. PMID 12836162 DOI: 10.1002/jnr.10649  0.6
2003 Schmidt J, Metselaar JM, Wauben MH, Toyka KV, Storm G, Gold R. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain : a Journal of Neurology. 126: 1895-904. PMID 12805101 DOI: 10.1093/brain/awg176  0.6
2003 Toyka KV, Gold R. The pathogenesis of CIDP: rationale for treatment with immunomodulatory agents. Neurology. 60: S2-7. PMID 12707416  0.6
2003 Samsam M, Mi W, Wessig C, Zielasek J, Toyka KV, Coleman MP, Martini R. The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 2833-9. PMID 12684470  0.6
2003 Krampfl K, Mohammadi B, Buchwald B, Jahn K, Dengler R, Toyka KV, Bufler J. IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels Muscle and Nerve. 27: 435-441. PMID 12661044 DOI: 10.1002/mus.10349  0.6
2003 Müllges W, Franke D, Reents W, Babin-Ebell J, Toyka KV. Reduced rate of microembolism by optimized aortic cannula position does not influence early postoperative cognitive performance in CABG patients. Cerebrovascular Diseases (Basel, Switzerland). 15: 192-8. PMID 12646779 DOI: 10.1159/000068827  0.6
2003 Kobsar I, Berghoff M, Samsam M, Wessig C, Mäurer M, Toyka KV, Martini R. Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1 Brain. 126: 804-813. PMID 12615640 DOI: 10.1093/brain/awg072  0.6
2003 Schneider-Gold C, Beck M, Wessig C, George A, Kele H, Reiners K, Toyka KV. Creatine monohydrate in DM2/PROMM: A double-blind placebo-controlled clinical study Neurology. 60: 500-502. PMID 12578937  0.6
2003 Chan A, Papadimitriou C, Graf W, Toyka KV, Gold R. Effects of polyclonal immunoglobulins and other immunomodulatory agents on microglial phagocytosis of apoptotic inflammatory T-cells. Journal of Neuroimmunology. 135: 161-5. PMID 12576237 DOI: 10.1016/S0165-5728(02)00433-2  0.6
2003 Bayas A, Kruse N, Moriabadi NF, Weber F, Hummel V, Wohleben G, Gold R, Toyka KV, Rieckmann P. Modulation of cytokine mRNA expression by brain-derived neurotrophic factor and nerve growth factor in human immune cells Neuroscience Letters. 335: 155-158. PMID 12531456 DOI: 10.1016/S0304-3940(02)01152-7  0.6
2003 Toyka KV. Therapeutic value of azathioprine in myasthenia gravis statement of the German neurological society | Therapeutischer stellenwert von azathioprin bei der behandlung der myasthenia gravis: Stellungnahme der Deutschen gesellschaft für neurologie Aktuelle Neurologie. 30: 1-2. DOI: 10.1055/s-2003-37064  0.6
2003 Hohlfeld R, Melms A, Schneider C, Toyka KV, Drachman DB. Therapy of Myasthenia Gravis and Myasthenic Syndromes Neurological Disorders: Course and Treatment: Second Edition. 1341-1362. DOI: 10.1016/B978-012125831-3/50289-6  0.6
2003 Müllges W, Gold R, Toyka KV. Myasthenic crisis | Myasthene krise Intensivmedizin Und Notfallmedizin. 40: 111-123. DOI: 10.1007/s00390-003-0369-0  0.6
2003 Mäurer M, Toyka KV, Gold R. Therapy of immune mediated neuropathies | Therapie immunvermittelter neuropathien Nervenheilkunde. 22: 131-135.  0.6
2002 Mäurer M, Toyka KV, Gold R. Cellular immunity in inflammatory autoimmune neuropathies Revue Neurologique. 158: 6S7-6S15. PMID 12690655  0.6
2002 Flachenecker P, Kümpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, Trenkwalder C, Toyka KV. Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters Multiple Sclerosis. 8: 523-526. PMID 12474995 DOI: 10.1191/1352458502ms839oa  0.6
2002 Hoffmann V, Hardt C, Mäurer M, Linker R, Gold R, Toyka KV, Sendtner M, Rieckmann P. A null mutation in the CNTF gene is not associated with early onset of multiple sclerosis [2] (multiple letters) Archives of Neurology. 59: 1974-1975. PMID 12470191 DOI: 10.1001/archneur.59.12.1974  0.6
2002 Buchwald B, Ahangari R, Toyka KV. Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction. Neuroscience Letters. 334: 25-8. PMID 12431767 DOI: 10.1016/S0304-3940(02)01037-6  0.6
2002 Toyka KV, Müller B, Reichmann H. "Atraumatic" Sprotte needle reduces the incidence of post-lumbar puncture headaches. Neurology. 59: 1120; author reply 1. PMID 12370487  0.6
2002 Rieckmann P, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, ... ... Toyka KV, et al. Escalating immunomodulatory therapy of multiple sclerosis - New aspects and practical application | Immunmodulatorische stufentherapie der multiplen sklerose: Neue aspekte und praktische umsetzung, März 2002 Nervenarzt. 73: 556-563. PMID 12243005 DOI: 10.1007/s00115-002-1328-x  0.6
2002 Magnus T, Chan A, Linker RA, Toyka KV, Gold R. Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: implications for the role of glial cells in the inflamed central nervous system. Journal of Neuropathology and Experimental Neurology. 61: 760-6. PMID 12230322  0.6
2002 Magnus T, Chan A, Savill J, Toyka KV, Gold R. Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications. Journal of Neuroimmunology. 130: 1-9. PMID 12225883 DOI: 10.1016/S0165-5728(02)00212-6  0.6
2002 Müllges W, Babin-Ebell J, Reents W, Toyka KV. Cognitive performance after coronary artery bypass grafting: a follow-up study. Neurology. 59: 741-3. PMID 12221167  0.6
2002 Sommer C, Lindenlaub T, Zillikens D, Toyka KV, Naumann M. Selective loss of cholinergic sudomotor fibers causes anhidrosis in Ross syndrome. Annals of Neurology. 52: 247-50. PMID 12210801 DOI: 10.1002/ana.10256  0.6
2002 Weishaupt A, Kuhlmann T, Schönrock LM, Toyka KV, Brück W, Gold R. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis. Acta Neuropathologica. 104: 385-90. PMID 12200625 DOI: 10.1007/s00401-002-0568-y  0.6
2002 Flachenecker P, Jung S, Rieckmann P, Toyka KV. sICAM-1 is not a marker for disease activity in the relapse-free interval of multiple sclerosis--a cross-sectional pilot study. Journal of Neurology. 249: 1001-3. PMID 12195444 DOI: 10.1007/s00415-002-0772-7  0.6
2002 Bayas A, Hummel V, Kallmann BA, Karch C, Toyka KV, Rieckmann P. Human cerebral endothelial cells are a potential source for bioactive BDNF Cytokine. 19: 55-58. PMID 12182839 DOI: 10.1006/cyto.2002.0892  0.6
2002 Offenhäusser M, Herr AS, Hartkamp J, Wauben M, Magnus T, Grauer O, Seubert S, Weishaupt A, Toyka KV, Gold R, Troppmair J. Truncation of the neuritogenic peptide bP2(60-70) results in the generation of altered peptide ligands with the potential to interfere with T cell activation. Journal of Neuroimmunology. 129: 97-105. PMID 12161025 DOI: 10.1016/S0165-5728(02)00183-2  0.6
2002 Kahl KG, Kruse N, Toyka KV, Rieckmann P. Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis. Journal of the Neurological Sciences. 200: 53-5. PMID 12127676 DOI: 10.1016/S0022-510X(02)00136-3  0.6
2002 Buchwald B, Ahangari R, Weishaupt A, Toyka KV. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome. Annals of Neurology. 51: 673-80. PMID 12112071 DOI: 10.1002/ana.10205  0.6
2002 Schäfers M, Schmidt C, Vogel C, Toyka KV, Sommer C. Tumor necrosis factor-alpha (TNF) regulates the expression of ICAM-1 predominantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve. Acta Neuropathologica. 104: 197-205. PMID 12111363 DOI: 10.1007/s00401-002-0541-9  0.6
2002 Buttman M, Marziniak M, Toyka KV, Sommer C, Altland K. "sporadic" familial amyloidotic polyneuropathy in a German patient with B cell lymphocytic leukaemia [1] Journal of Neurology Neurosurgery and Psychiatry. 73: 86-87. PMID 12082059 DOI: 10.1136/jnnp.73.1.86  0.6
2002 Mäurer M, Toyka KV, Gold R. Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models. Neuromuscular Disorders : Nmd. 12: 405-14. PMID 12062260 DOI: 10.1016/S0960-8966(01)00302-9  0.6
2002 Linker RA, Mäurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nature Medicine. 8: 620-4. PMID 12042814 DOI: 10.1038/nm0602-620  0.6
2002 Beer M, Schneider C, Köstler H, Buchner S, Sandstede J, Toyka KV, Hahn D. Quantitative analysis of energy metabolism in human muscle using SLOOP 31P-MR-spectroscopy Rofo Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren. 174: 573-578. PMID 11997856 DOI: 10.1055/s-2002-28273  0.6
2002 Giess R, Holtmann B, Braga M, Grimm T, Müller-Myhsok B, Toyka KV, Sendtner M. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene. American Journal of Human Genetics. 70: 1277-86. PMID 11951178 DOI: 10.1086/340427  0.6
2002 Toyka KV, Zielasek J, Stoll G. Myelin-derived glycolipids and animal models of Guillain-Barré syndrome. Annals of Neurology. 51: 532; author reply 53. PMID 11921062 DOI: 10.1002/ana.10140  0.6
2002 Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain : a Journal of Neurology. 125: 823-34. PMID 11912115 DOI: 10.1093/brain/awf070  0.6
2002 Giess R, Mäurer M, Linker R, Gold R, Warmuth-Metz M, Toyka KV, Sendtner M, Rieckmann P. Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. Archives of Neurology. 59: 407-9. PMID 11890844  0.6
2002 Schneider C, Gold R, Schäfers M, Toyka KV. Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome Muscle and Nerve. 25: 286-288. PMID 11870700 DOI: 10.1002/mus.10026  0.6
2002 Willison H, Stoll G, Toyka KV, Berger T, Hartung HP. Autoimmunity and inflammation in the peripheral nervous system. Trends in Neurosciences. 25: 127-9. PMID 11852137 DOI: 10.1016/S0166-2236(00)02120-2  0.6
2002 Weiss H, Rastan V, Müllges W, Wagner RF, Toyka KV. Psychotic symptoms and emotional distress in patients with Guillain-Barré syndrome European Neurology. 47: 74-78. PMID 11844894 DOI: 10.1159/000047956  0.6
2002 Leussink VI, Zettl UK, Jander S, Pepinsky RB, Lobb RR, Stoll G, Toyka KV, Gold R. Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritis Acta Neuropathologica. 103: 131-136. PMID 11810178 DOI: 10.1007/s004010100444  0.6
2002 Weilbach FX, Toyka KV. Does Down's syndrome protect against multiple sclerosis? European Neurology. 47: 52-55. PMID 11803193  0.6
2002 Linker RA, Toyka KV, Gold R. EAE in genetically modified animals: Identification of targets for pathogenesis and immunotherapy of multiple sclerosis International Ms Journal. 9: 42-51.  0.6
2002 Flachenecker P, Toyka KV, Reiners K. Diagnosis of autonomic dysfunction in Guillain-Barré syndrome | Diagnostik kardiovaskulärer autonomer störungen beim Guillain-Barré-syndrom Intensiv- Und Notfallbehandlung. 27: 120-130.  0.6
2001 Flachenecker P, Reiners K, Krauser M, Wolf A, Toyka KV. Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability Multiple Sclerosis. 7: 327-334. PMID 11724449 DOI: 10.1191/135245801681138031  0.6
2001 Stienekemeier M, Falk K, Rötzschke O, Weishaupt A, Schneider C, Toyka KV, Gold R, Strominger JL. Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope. Proceedings of the National Academy of Sciences of the United States of America. 98: 13872-7. PMID 11717443 DOI: 10.1073/pnas.241504598  0.6
2001 Magnus T, Chan A, Grauer O, Toyka KV, Gold R. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation Journal of Immunology. 167: 5004-5010. PMID 11673508  0.6
2001 Weishaupt A, Schönrock LM, Stienekemeier M, Toyka KV, Gold R. Glucocorticosteroids modulate antigen-induced T cell apoptosis in experimental autoimmune neuritis and cause T cell proliferation in situ Acta Neuropathologica. 102: 75-82. PMID 11547954  0.6
2001 Sommer C, Lindenlaub T, Teuteberg P, Schäfers M, Hartung T, Toyka KV. Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy Brain Research. 913: 86-89. PMID 11532251 DOI: 10.1016/S0006-8993(01)02743-3  0.6
2001 Schneider C, Gold R, Reiners K, Toyka KV. Mycophenolate mofetil in the therapy of severe myasthenia gravis European Neurology. 46: 79-82. PMID 11528156 DOI: 10.1159/000050768  0.6
2001 Schneider C, Reiners K, Toyka KV. Steinert's disease and Ricker's syndrome: Mytonic muscular disorders with multisystemic manifestations | Myotone dystrophie (DM/Curschmann-Steinert-Erkrankung) und proximale myotone myopathie (PROMM/Ricker-syndrom): Myotone muskelerkrankungen mit multisystemischen manifestationen Nervenarzt. 72: 618-624. PMID 11519202 DOI: 10.1007/s001150170061  0.6
2001 Flachenecker P, Toyka KV, Reiners K. Cardiac arrhythmias in Guillain-Barré syndrome: A review of the diagnosis of rare but potentially life-threatening complications | Herzrhythmusstörungen beim Guillain-Barré-syndrom: Eine übersicht zur diagnostik einer seltenen, aber potenziell lebensbedrohlichen komplikation Nervenarzt. 72: 610-617. PMID 11519201 DOI: 10.1007/s001150170060  0.6
2001 Grauer O, Offenhäusser M, Schmidt J, Toyka KV, Gold R. Glucocorticosteroid therapy in optic neuritis and multiple sclerosis: Evidence from clinical studies and practical recommendations | Glukokortikosteroid-therapie bei optikusneuritis und multipler sklerose: Evidenz aus klinischen studien und praktische empfehlungen Nervenarzt. 72: 577-589. PMID 11519198 DOI: 10.1007/s001150170057  0.6
2001 Sommer C, Schäfers M, Marziniak M, Toyka KV. Etanercept reduces hyperalgesia in experimental painful neuropathy Journal of the Peripheral Nervous System. 6: 67-72. PMID 11446385 DOI: 10.1046/j.1529-8027.2001.01010.x  0.6
2001 Schmidt J, Stürzebecher S, Toyka KV, Gold R. Interferon-β treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration Journal of Neuroscience Research. 65: 59-57. PMID 11433430 DOI: 10.1002/jnr.1128  0.6
2001 Gold R, Buttgereit F, Toyka KV. Mechanism of action of glucocorticosteroid hormones: Possible implications for therapy of neuroimmunological disorders Journal of Neuroimmunology. 117: 1-8. PMID 11430999 DOI: 10.1016/S0165-5728(01)00330-7  0.6
2001 Mäurer M, Schmid CD, Bootz F, Zielasek J, Toyka KV, Oehen S, Martini R. Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants. Molecular and Cellular Neurosciences. 17: 1094-101. PMID 11414797 DOI: 10.1006/mcne.2001.0990  0.6
2001 Beer M, Sandstede J, Weilbach F, Spindler M, Buchner S, Krug A, Köstler H, Pabst T, Kenn W, Landschütz W, Von Kienlin M, Toyka KV, Ertl C, Gold R, Hahn D. Cardiac metabolism and function in patients with multiple sclerosis: A combined 31P-MR-spectroscopy and MRI study | Metabolische und funktionelle veränderungen des herzens bel patienten mit multiplier sklerose: Eine MR-spektroskopische und MR-tomographische studie Rofo Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren. 173: 399-404. PMID 11414146 DOI: 10.1055/s-2001-13339  0.6
2001 Weishaupt A, Brück W, Hartung T, Toyka KV, Gold R. Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-α Neuroscience Letters. 306: 77-80. PMID 11403962 DOI: 10.1016/S0304-3940(01)01877-8  0.6
2001 Jung S, Gaupp S, Hartung HP, Toyka KV. Oral tolerance in experimental autoimmune neuritis (EAN) of the Lewis rat II. Adjuvant effects and bystander suppression in P2 peptide-induced EAN Journal of Neuroimmunology. 116: 21-28. PMID 11311326 DOI: 10.1016/S0165-5728(01)00276-4  0.6
2001 Wessig C, Buchwald B, Toyka KV, Martini R. Miller Fisher syndrome: Immunofluorescence and immunoelectron microscopic localization of IgG at the mouse neuromuscular junction Acta Neuropathologica. 101: 239-244. PMID 11307623  0.6
2001 Hummel V, Kallmann BA, Wagner S, Füller T, Bayas A, Tonn JC, Benveniste EN, Toyka KV, Rieckmann P. Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. Journal of Neuropathology and Experimental Neurology. 60: 320-7. PMID 11305867  0.6
2001 Moriabadi NF, Niewiesk S, Kruse N, Jung S, Weissbrich B, Ter Meulen V, Toyka KV, Rieckmann P. Influenza vaccination in MS: Absence of T-cell response against white matter proteins Neurology. 56: 938-943. PMID 11294933  0.6
2001 Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology. 56: 758-65. PMID 11274311  0.6
2001 Carenini S, Mäurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, Raivich G, Martini R. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. The Journal of Cell Biology. 152: 301-8. PMID 11266447 DOI: 10.1083/jcb.152.2.301  0.6
2001 Büttner U, Chofflon M, Hess K, Kappos L, Kesselring J, Ludin HP, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Freimüller M, Hartung HP, Kollegger H, Kristoferitsch W, ... ... Toyka KV, et al. Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement | Immunmodulatorische stufentherapie der multiplen sklerose. 1. Ergänzung: Dezember 2000 Nervenarzt. 72: 150-157. PMID 11256151 DOI: 10.1007/s001150050729  0.6
2001 Mäurer M, Gold R, Toyka KV, Rieckmann P. Treatment of multiple sclerosis with recombinant interferon-β preparations. Views on pharmocology and dosage | Behandlung der schubförmigen multiplen sklerose mit rekombinanten interferon-β-präparaten. Aspekte zur pharmakologie und dosierung Nervenarzt. 72: 108-116. PMID 11256144 DOI: 10.1007/s001150050722  0.6
2001 Winterholler MGM, Erbguth FJ, Wolf S, Kat S, Naumann M, Giess R, Schwager K, Toyka KV. Botulinum toxin for the treatment of sialorrhoea in ALS: Serious side effects of a transductal approach [13] (multiple letters) Journal of Neurology Neurosurgery and Psychiatry. 70: 417-418. PMID 11248905 DOI: 10.1136/jnnp.70.3.417  0.6
2001 Leussink VI, Jung S, Merschdorf U, Toyka KV, Gold R. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes Archives of Neurology. 58: 91-97. PMID 11176941  0.6
2001 Kieseier BC, Schneider C, Clements JM, Gearing AJH, Gold R, Toyka KV, Hartung HP. Expression of specific matrix metalloproteinases in inflammatory myopathies Brain. 124: 341-351. PMID 11157561  0.6
2001 Kruse N, Moriabadi NF, Toyka KV, Rieckmann P. Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cells Journal of Immunological Methods. 247: 131-139. PMID 11150544 DOI: 10.1016/S0022-1759(00)00316-1  0.6
2001 Buchwald B, Bufler J, Carpo M, Heidenreich F, Pitz R, Dudel J, Nobile-Orazio E, Toyka KV. Combined pre- and postsynatic action of IgG antibodies in Miller Fisher syndrome Neurology. 56: 67-74. PMID 11148238 DOI: 10.1212/WNL.56.1.67  0.6
2001 Weilbach FX, Rieckmann P, Gold R, Toyka KV. Multiple sclerosis: Critical discussion of controversial and complementary therapies based on current pathogenetic hypotheses | Multiple sklerose: Kritische betrachtung umstrittener und komplementärmedizinischer therapien auf der grundlage aktueller hypothesen zur pathogenese Aktuelle Neurologie. 28: 31-38. DOI: 10.1055/s-2001-10721  0.6
2001 Gold R, Reiners K, Toyka KV. Immunoglobulins in the treatment of neuromuscular autoimmune disorders | Therapie mit immunglobulinen bei neuromuskulären autoimmunerkrankungen Nervenheilkunde. 20: 287-294.  0.6
2000 Weishaupt A, Jander S, Bruck W, Kuhlmann T, Stienekemeier M, Hartung T, Toyka KV, Stoll G, Gold R. Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: Rapid induction of Th1-type cytokines and inducible nitric oxide synthase Journal of Immunology. 165: 7157-7163. PMID 11120847  0.6
2000 George A, Marziniak M, Schäfers M, Toyka KV, Sommer C. Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-α, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin Pain. 88: 267-275. PMID 11068114 DOI: 10.1016/S0304-3959(00)00333-X  0.6
2000 Kieseier BC, Krivacic K, Jung S, Pischel H, Toyka KV, Ransohoff RM, Hartung HP. Sequential expression of chemokines in experimental autoimmune neuritis Journal of Neuroimmunology. 110: 121-129. PMID 11024541 DOI: 10.1016/S0165-5728(00)00323-4  0.6
2000 Kress W, Mueller-Myhsok B, Ricker K, Schneider C, Koch MC, Toyka KV, Mueller CR, Grimm T. Proof of genetic heterogeneity in the proximal myotonic myopathy syndrome (PROMM) and its relationship to myotonic dystrophy type 2 (DM2). Neuromuscular Disorders : Nmd. 10: 478-80. PMID 10996776 DOI: 10.1016/S0960-8966(00)00129-2  0.6
1999 Zielasek J, Toyka KV. Nerve Conduction Abnormalities and Neuromyotonia in Genetically Engineered Mouse Models of Human Hereditary Neuropathies. Annals of the New York Academy of Sciences. 883: 310-320. PMID 29086933 DOI: 10.1111/j.1749-6632.1999.tb08593.x  0.64
Show low-probability matches.